Skip to content

Artificial Pancreas

At JDRF’s Artificial Pancreas Program, we are working to provide technology that is small, user-friendly and accurate, so that people with type 1 diabetes (T1D) can get through the day without needing to check blood-sugar levels or dose insulin as often.

Our Approach

In people with T1D, the body often defies even the most vigilant efforts to keep blood-sugar levels normal. Artificial pancreas systems, however, take over much of the blood-sugar management. They monitor blood-glucose levels with a continuous glucose monitor (CGM) and use an algorithm to automatically provide the right amount of insulin at the right time—much like a normal pancreas would do naturally.

  • Create miniaturized devices

    that go unnoticed by everyone but the wearer

  • Enable open systems

    so an insulin pump, a CGM and algorithm can “talk” to each other, regardless of the manufacturer

  • Drive algorithm advancements

    to control blood sugar automatically, even while eating or exercising

“Before I had an artificial pancreas system, I would constantly make micro-adjustments for fear of going too high or too low. Now, my artificial pancreas does it for me, and provides insulin as a result of its readings. Because of this, I think about T1D a fraction of the time, leading me to focus my efforts on more important things.”

Kady T.

28 years old, diagnosed at age 5

Kady T.

Many Paths, One Purpose

Our research into artificial pancreas devices and technologies is just one potential pathway to finding a cure for T1D. Explore JDRF’s ambitious research portfolio.

All Research

Looking Ahead

To date, more than $110 million has been invested by JDRF. Future research will continue to automate blood-sugar management, dramatically reduce T1D-related risks and reduce the burden on people living with the disease.